Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Lipidomic signature of stroke recurrence after transient ischemic attack

  • Purroy, Francisco
  • Ois Santiago, Angel Javier
  • Jové, Mariona
  • Arque, Gloria
  • Sol, Joaquim
  • Mauri Capdevila, Gerard
  • Rodríguez-Campello, Ana
  • Pamplona, Reinald
  • Portero Otín, Manuel
  • Roquer, Jaume
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition.The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR., This study was supported by the Government of Catalonia-Agència de Gestió d'Ajuts Universitaris i de Recerca (FP: 2017SGR1628 and 2021SGR01479; RP: 2021SGR00990); Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future" and "A way to build Europe") (FP: PI17-01725, PI14/01574; M.P-O: PI 17-00134, 20-0155); the Spanish Ministry of Science, Innovation and Universities (RP: RTI2018-099200-B-I00 and PID2022-143140OB-I00); the Department of Health (RP: SLT002/16/00250); and the INVICTUS plus Research Network (Carlos III Health Institute) (FP, CT and GA: RD16-0019-0017; TS: RD16-0019-0012; AO and JR: RD16-0019-0012; AC: RD16-0019-0006. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipidomic signature of stroke recurrence after transient ischemic attack

  • Purroy Garcia, Francisco
  • Ois, Ángel
  • Arque, Gloria
  • Sol, Joaquim
  • Mauri-Capdevila, Gerard
  • Rodríguez-Campello, Ana
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Roquer, Jaume
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition. The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR., Tis study was supported by the Government of Catalonia-Agència de Gestió d’Ajuts Universitaris i de Recerca (FP: 2017SGR1628 and 2021SGR01479; RP: 2021SGR00990); Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future" and "A way to build Europe") (FP: PI17-01725, PI14/01574; M.P-O: PI 17-00134, 20-0155); the Spanish Ministry of Science, Innovation and Universities (RP: RTI2018-099200-B-I00 and PID2022-143140OB-I00); the Department of Health (RP: SLT002/16/00250); and the INVICTUS plus Research Network (Carlos III Health Institute) (FP, CT and GA: RD16-0019-0017; TS: RD16-0019-0012; AO and JR: RD16-0019-0012; AC: RD16-0019-0006. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya)
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipidomic alterations in the cerebral cortex and white matter in sporadic Alzheimer's disease.

  • Obis Monné, Èlia
  • Sol, Joaquim
  • Andrés Benito, Pol
  • Martín Garí, Meritxell
  • Mota Martorell, Natàlia
  • Galo-Licona, José Daniel
  • Piñol Ripoll, Gerard
  • Portero Otín, Manuel
  • Ferrer, Isidro
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Non-targeted LC-MS/MS-based lipidomic analysis was conducted in post-mortem human grey matter frontal cortex area 8 (GM) and white matter of the frontal lobe centrum semi-ovale (WM) to identify lipidome fingerprints in middle-aged individuals with no neurofibrillary tangles and senile plaques, and cases at progressive stages of sporadic Alzheimer's disease (sAD). Complementary data were obtained using RT-qPCR and immunohistochemistry. The results showed that WM presents an adaptive lipid phenotype resistant to lipid peroxidation, characterized by a lower fatty acid unsaturation, peroxidizability index, and higher ether lipid content than the GM. Changes in the lipidomic profile are more marked in the WM than in GM in AD with disease progression. Four functional categories are associated with the different lipid classes affected in sAD: membrane structural composition, bioenergetics, antioxidant protection, and bioactive lipids, with deleterious consequences affecting both neurons and glial cells favoring disease progression., This research was funded by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00, and PID2022-143140OB-I00), the Diputació de Lleida-IRBLleida (PP10605 – PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) to R.P., and Instituto de Salud Carlos III grant (PI20/00155) to M.P.O. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. Part of the study was also funded by “La Caixa” Foundation under the agreement LCF/PR/HR19/ 52160007: HR18-00452 to I.F. M.J. is a ‘Serra-Hunter’ Fellow. We thank T. Yohannan for editorial help.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome

  • Sol, Joaquim
  • Obis Monné, Èlia
  • Mota Martorell, Natàlia
  • Pradas Barriga, Irene
  • Galo-Licona, José Daniel
  • Martín Garí, Meritxell
  • Fernández Bernal, Anna
  • Ortega Bravo, Marta
  • Mayneris Perxachs, Jordi
  • Borrás, Consuelo
  • Viña Ribes, José
  • Fuente, Monica de la
  • Mate, Ianire
  • Biarnés, Carles
  • Pedraza, Salvador
  • Vilanova, Joan Carles
  • Brugada, Ramon
  • Ramos, Rafel
  • Serena, Joaquín
  • Ramió Torrentà, Lluís
  • Pineda, Víctor
  • Daunis-i-Estadella, Pepus
  • Thió-Henestrosa, Santiago
  • Barretina Ginesta, Jordi
  • Garre Olmo, Josep
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
  • Puig, Josep
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Aging biology entails a cell/tissue deregulated metabolism that affects all levels of biological organization. Therefore, the application of “omic” techniques that are closer to phenotype, such as metabolomics, to the study of the aging process should be a turning point in the definition of cellular processes involved. The main objective of the present study was to describe the changes in plasma metabolome associated with biological aging and the role of sex in the metabolic regulation during aging. A high-throughput untargeted metabolomic analysis was applied in plasma samples to detect hub metabolites and biomarkers of aging incorporating a sex/gender perspective. A cohort of 1030 healthy human adults (45.9% females, and 54.1% males) from 50 to 98 years of age was used. Results were validated using two independent cohorts (1: n = 146, 53% females, 30–100 years old; 2: n = 68, 70% females, 19–107 years old). Metabolites related to lipid and aromatic amino acid (AAA) metabolisms arose as the main metabolic pathways affected by age, with a high influence of sex. Globally, we describe changes in bioenergetic pathways that point to a decrease in mitochondrial β-oxidation and an accumulation of unsaturated fatty acids and acylcarnitines that could be responsible for the increment of oxidative damage and inflammation characteristic of this physiological process. Furthermore, we describe for the first time the importance of gut-derived AAA catabolites in the aging process describing novel biomarkers that could contribute to better understand this physiological process but also age-related diseases., This research was funded by the Spanish Ministry of Science,Innovation, and Universities (grant RTI2018-099200-B- I00, and PID2022-143140OB-I00, co-funded by the European Regional Development Fund. “A way to build Europe”), and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2021SGR00990] and Department of Health [SLT002/16/00250])to R.P. The work is also supported by “la Caixa” Foundation (Grant Agreement LCF/PR/HR21/52410002) to M.J. IRBLleida is a CERCAProgramme/Generalitat of Catalonia. This work was also partiallysupported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, PI20/01090, and PI21/01361 (co-funded by the European Regional Development Fund. “A way to make Europe”), and the Catalan Government (AGAUR,#SGR2017-0734, ICREA Academia Award 2021) to J.M.F-R.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Cantero, José Luís
  • Pamplona Gras, Reinald
Background Oxidative stress is considered to play an important role in the pathogenesis of Alzheimer's disease (AD). It has been observed that oxidative damage to specific protein targets affecting particular functional networks is one of the mechanisms by which oxidative stress contributes to neuronal failure and consequently loss of cognition and AD progression. Studies are lacking in which oxidative damage is measured at both systemic and central fluid levels and in the same cohort of patients. We aimed to determine the levels of both plasma and cerebrospinal fluid (CSF) nonenzymatic protein damage in patients in the continuum of AD and to evaluate the relation of this damage with clinical progression from mild cognitive impairment (MCI) to AD. Methods Different markers of nonenzymatic post-translational protein modification, mostly from oxidative processes, were detected and quantified in plasma and CSF by isotope dilution gas chromatography‒mass spectrometry using selected ion monitoring (SIM-GC/MS) for 289 subjects: 103 AD, 92 MCI, and 94 control subjects. Characteristics of the study population such as age, sex, Mini-mental state examination, CSF AD biomarkers, and APOE ϵ4, were also considered. Results Forty-seven (52.8%) MCI patients progressed to AD during follow-up (58 ± 12.5 months). After controlling for age, sex, and APOE ϵ4 allele, plasma and CSF concentrations of protein damage markers were not associated with either diagnosis of AD or MCI. The CSF levels of nonenzymatic protein damage markers were associated with none of the CSF AD biomarkers. In addition, neither in CSF nor in plasma were the levels of protein damage associated with the MCI to AD progression. Conclusion The lack of association between both CSF and plasma concentrations of nonenzymatic protein damage markers and AD diagnosis and progression suggests that oxidative damage in AD is a pathogenic mechanism specifically expressed at the cell-tissue level, not in extracellular fluids., This research was supported by the Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050), and the Agency for the Management of University and Research Grants (2021SGR 00761) to GPR. The spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00 and PID2022-143140OB-I00), the Diputacio ´ de Lleida (PP10605 - PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. The Spanish Ministry of Economy and Competitiveness (PID2020-119978RB-I00), CIBERNED, Alzheimer’s Association (AARG-NTF-22- 924702), the Junta de Andalucía (PY20_00858), and the AndalucíaFEDER Program (UPO-1380913) to JLC. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Huerto Vilas, Raquel
  • Carnes Vendrell, Anna
  • Sol, Joaquim
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Aberrant lipid metabolism has been strongly linked to Alzheimer’s disease (AD) pathogenesis. However, the role of lipids in the pathophysiological processes of AD and their clinical progression is unclear. We hypothesized that plasma lipids are associated with the pathological hallmarks of AD, progression from mild cognitive impairment (MCI) to AD, and the rate of cognitive decline in MCI patients. To evaluate our hypotheses, we analysed the plasma lipidome profile by liquid chromatography coupled to mass spectrometry in an LC-ESI-QTOF-MS/MS platform for 213 subjects recruited consecutively: 104 AD, 89 MCI, and 20 control subjects. Forty-seven (52.8%) MCI patients progressed to AD during follow-up (58 ± 12.5 months). We found that higher plasma levels of sphingomyelin SM(36:0) and diglyceride DG(44:3) were associated with an increased risk of amyloid beta 42 (Aβ42) positivity in CSF, while levels of SM(40:1) were associated with a reduced risk. Higher plasma levels of ether-linked triglyceride TG(O-60:10) were negatively associated with pathological levels of phosphorylated tau in CSF. Plasma levels of fatty acid ester of hydroxy fatty acid FAHFA(34:0) and ether-linked phosphatidylcholine PC(O-36:1) were positively associated with pathological levels of total tau in CSF. Regarding the plasma lipids most associated with progression from MCI to AD, our analysis detected phosphatidyl-ethanolamine plasmalogen PE(P-36:4), TG(59:12), TG(46:0), and TG(O-62:7). Furthermore, TG(O-62:7) was the lipid that was most strongly associated with the rate of progression. In conclusion, our results indicate that neutral and ether-linked lipids are involved in the pathophysiological processes of AD and the progression from MCI to AD dementia, suggesting the involvement of lipid-mediated antioxidant mechanisms in AD., We would like to express our sincere gratitude to all of the patients and all of the members of the dementia unit at the Hospital Universitari Santa Maria. Mariona Jové is a ‘Serra-Hunter’ Fellow. Farida Dakterzada was supported by the Agency for Management of University and Research Grants and the European Social Fund (FI_B100153). The Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (PI22/01687) and Agency for Management of University and Research Grants (2021SGR00761) to Gerard Piñol-Ripoll. The Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades) (grant RTI2018-099200-B-I00 and PID2022-143140- OB-I00), the IRBLleida-Diputació de Lleida (PP10605- PIRS2021), and the Government of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) to Reinald Pamplona. This study was co-financed by FEDER funds from the European Union 'A way to build Europe'. IRBLleida is a CERCA Program of the Government of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Obis Monné, Èlia
  • Sol, Joaquim
  • Martín Garí, Meritxell
  • Ferrer, Isidre
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
One of the richest tissues in lipid content and diversity of the human body is the brain. The human brain is constitutively highly vulnerable to oxidative stress. This oxidative stress is a determinant in brain aging, as well as in the onset and progression of sporadic (late-onset) Alzheimer’s disease (sAD). Glycerophospholipids are the main lipid category widely distributed in neural cell membranes, with a very significant presence for the ether lipid subclass. Ether lipids have played a key role in the evolution of the human brain compositional specificity and functionality. Ether lipids determine the neural membrane structural and functional properties, membrane trafficking, cell signaling and antioxidant defense mechanisms. Here, we explore the idea that ether lipids actively participate in the pathogenesis of sAD. Firstly, we evaluate the quantitative relevance of ether lipids in the human brain composition, as well as their role in the human brain evolution. Then, we analyze the implications of ether lipids in neural cell physiology, highlighting their inherent antioxidant properties. Finally, we discuss changes in ether lipid content associated with sAD and their physiopathological implications, and propose a mechanism that, as a vicious cycle, explains the potential significance of ether lipids in sAD., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (grants RTI2018-099200-B-I00 and PID2022-143140OB-I00), the Diputació de Lleida (PP10605—PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic alterations in the cerebral cortex and white matter in sporadic Alzheimer's disease.

  • Obis Monné, Èlia
  • Sol, Joaquim
  • Andrés Benito, Pol
  • Martín Garí, Meritxell
  • Mota Martorell, Natàlia
  • Galo-Licona, José Daniel
  • Piñol Ripoll, Gerard
  • Portero Otín, Manuel
  • Ferrer, Isidro
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Non-targeted LC-MS/MS-based lipidomic analysis was conducted in post-mortem human grey matter frontal cortex area 8 (GM) and white matter of the frontal lobe centrum semi-ovale (WM) to identify lipidome fingerprints in middle-aged individuals with no neurofibrillary tangles and senile plaques, and cases at progressive stages of sporadic Alzheimer's disease (sAD). Complementary data were obtained using RT-qPCR and immunohistochemistry. The results showed that WM presents an adaptive lipid phenotype resistant to lipid peroxidation, characterized by a lower fatty acid unsaturation, peroxidizability index, and higher ether lipid content than the GM. Changes in the lipidomic profile are more marked in the WM than in GM in AD with disease progression. Four functional categories are associated with the different lipid classes affected in sAD: membrane structural composition, bioenergetics, antioxidant protection, and bioactive lipids, with deleterious consequences affecting both neurons and glial cells favoring disease progression., This research was funded by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00, and PID2022-143140OB-I00), the Diputació de Lleida-IRBLleida (PP10605 – PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) to R.P., and Instituto de Salud Carlos III grant (PI20/00155) to M.P.O. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. Part of the study was also funded by “La Caixa” Foundation under the agreement LCF/PR/HR19/ 52160007: HR18-00452 to I.F. M.J. is a ‘Serra-Hunter’ Fellow. We thank T. Yohannan for editorial help.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Obis Monné, Èlia
  • Sol, Joaquim
  • Martín Garí, Meritxell
  • Ferrer, Isidre
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
One of the richest tissues in lipid content and diversity of the human body is the brain. The human brain is constitutively highly vulnerable to oxidative stress. This oxidative stress is a determinant in brain aging, as well as in the onset and progression of sporadic (late-onset) Alzheimer’s disease (sAD). Glycerophospholipids are the main lipid category widely distributed in neural cell membranes, with a very significant presence for the ether lipid subclass. Ether lipids have played a key role in the evolution of the human brain compositional specificity and functionality. Ether lipids determine the neural membrane structural and functional properties, membrane trafficking, cell signaling and antioxidant defense mechanisms. Here, we explore the idea that ether lipids actively participate in the pathogenesis of sAD. Firstly, we evaluate the quantitative relevance of ether lipids in the human brain composition, as well as their role in the human brain evolution. Then, we analyze the implications of ether lipids in neural cell physiology, highlighting their inherent antioxidant properties. Finally, we discuss changes in ether lipid content associated with sAD and their physiopathological implications, and propose a mechanism that, as a vicious cycle, explains the potential significance of ether lipids in sAD., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (grants RTI2018-099200-B-I00 and PID2022-143140OB-I00), the Diputació de Lleida (PP10605—PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Cantero, José Luís
  • Pamplona Gras, Reinald
Background Oxidative stress is considered to play an important role in the pathogenesis of Alzheimer's disease (AD). It has been observed that oxidative damage to specific protein targets affecting particular functional networks is one of the mechanisms by which oxidative stress contributes to neuronal failure and consequently loss of cognition and AD progression. Studies are lacking in which oxidative damage is measured at both systemic and central fluid levels and in the same cohort of patients. We aimed to determine the levels of both plasma and cerebrospinal fluid (CSF) nonenzymatic protein damage in patients in the continuum of AD and to evaluate the relation of this damage with clinical progression from mild cognitive impairment (MCI) to AD. Methods Different markers of nonenzymatic post-translational protein modification, mostly from oxidative processes, were detected and quantified in plasma and CSF by isotope dilution gas chromatography‒mass spectrometry using selected ion monitoring (SIM-GC/MS) for 289 subjects: 103 AD, 92 MCI, and 94 control subjects. Characteristics of the study population such as age, sex, Mini-mental state examination, CSF AD biomarkers, and APOE ϵ4, were also considered. Results Forty-seven (52.8%) MCI patients progressed to AD during follow-up (58 ± 12.5 months). After controlling for age, sex, and APOE ϵ4 allele, plasma and CSF concentrations of protein damage markers were not associated with either diagnosis of AD or MCI. The CSF levels of nonenzymatic protein damage markers were associated with none of the CSF AD biomarkers. In addition, neither in CSF nor in plasma were the levels of protein damage associated with the MCI to AD progression. Conclusion The lack of association between both CSF and plasma concentrations of nonenzymatic protein damage markers and AD diagnosis and progression suggests that oxidative damage in AD is a pathogenic mechanism specifically expressed at the cell-tissue level, not in extracellular fluids., This research was supported by the Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050), and the Agency for the Management of University and Research Grants (2021SGR 00761) to GPR. The spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00 and PID2022-143140OB-I00), the Diputacio ´ de Lleida (PP10605 - PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. The Spanish Ministry of Economy and Competitiveness (PID2020-119978RB-I00), CIBERNED, Alzheimer’s Association (AARG-NTF-22- 924702), the Junta de Andalucía (PY20_00858), and the AndalucíaFEDER Program (UPO-1380913) to JLC. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic signature of stroke recurrence after transient ischemic attack

  • Purroy Garcia, Francisco
  • Ois, Ángel
  • Arque, Gloria
  • Sol, Joaquim
  • Mauri-Capdevila, Gerard
  • Rodríguez-Campello, Ana
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Roquer, Jaume
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition. The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR., Tis study was supported by the Government of Catalonia-Agència de Gestió d’Ajuts Universitaris i de Recerca (FP: 2017SGR1628 and 2021SGR01479; RP: 2021SGR00990); Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future" and "A way to build Europe") (FP: PI17-01725, PI14/01574; M.P-O: PI 17-00134, 20-0155); the Spanish Ministry of Science, Innovation and Universities (RP: RTI2018-099200-B-I00 and PID2022-143140OB-I00); the Department of Health (RP: SLT002/16/00250); and the INVICTUS plus Research Network (Carlos III Health Institute) (FP, CT and GA: RD16-0019-0017; TS: RD16-0019-0012; AO and JR: RD16-0019-0012; AC: RD16-0019-0006. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Huerto Vilas, Raquel
  • Carnes Vendrell, Anna
  • Sol, Joaquim
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Aberrant lipid metabolism has been strongly linked to Alzheimer’s disease (AD) pathogenesis. However, the role of lipids in the pathophysiological processes of AD and their clinical progression is unclear. We hypothesized that plasma lipids are associated with the pathological hallmarks of AD, progression from mild cognitive impairment (MCI) to AD, and the rate of cognitive decline in MCI patients. To evaluate our hypotheses, we analysed the plasma lipidome profile by liquid chromatography coupled to mass spectrometry in an LC-ESI-QTOF-MS/MS platform for 213 subjects recruited consecutively: 104 AD, 89 MCI, and 20 control subjects. Forty-seven (52.8%) MCI patients progressed to AD during follow-up (58 ± 12.5 months). We found that higher plasma levels of sphingomyelin SM(36:0) and diglyceride DG(44:3) were associated with an increased risk of amyloid beta 42 (Aβ42) positivity in CSF, while levels of SM(40:1) were associated with a reduced risk. Higher plasma levels of ether-linked triglyceride TG(O-60:10) were negatively associated with pathological levels of phosphorylated tau in CSF. Plasma levels of fatty acid ester of hydroxy fatty acid FAHFA(34:0) and ether-linked phosphatidylcholine PC(O-36:1) were positively associated with pathological levels of total tau in CSF. Regarding the plasma lipids most associated with progression from MCI to AD, our analysis detected phosphatidyl-ethanolamine plasmalogen PE(P-36:4), TG(59:12), TG(46:0), and TG(O-62:7). Furthermore, TG(O-62:7) was the lipid that was most strongly associated with the rate of progression. In conclusion, our results indicate that neutral and ether-linked lipids are involved in the pathophysiological processes of AD and the progression from MCI to AD dementia, suggesting the involvement of lipid-mediated antioxidant mechanisms in AD., We would like to express our sincere gratitude to all of the patients and all of the members of the dementia unit at the Hospital Universitari Santa Maria. Mariona Jové is a ‘Serra-Hunter’ Fellow. Farida Dakterzada was supported by the Agency for Management of University and Research Grants and the European Social Fund (FI_B100153). The Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (PI22/01687) and Agency for Management of University and Research Grants (2021SGR00761) to Gerard Piñol-Ripoll. The Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades) (grant RTI2018-099200-B-I00 and PID2022-143140- OB-I00), the IRBLleida-Diputació de Lleida (PP10605- PIRS2021), and the Government of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) to Reinald Pamplona. This study was co-financed by FEDER funds from the European Union 'A way to build Europe'. IRBLleida is a CERCA Program of the Government of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome

  • Sol, Joaquim
  • Obis Monné, Èlia
  • Mota Martorell, Natàlia
  • Pradas Barriga, Irene
  • Galo-Licona, José Daniel
  • Martín Garí, Meritxell
  • Fernández Bernal, Anna
  • Ortega Bravo, Marta
  • Mayneris Perxachs, Jordi
  • Borrás, Consuelo
  • Viña Ribes, José
  • Fuente, Monica de la
  • Mate, Ianire
  • Biarnés, Carles
  • Pedraza, Salvador
  • Vilanova, Joan Carles
  • Brugada, Ramon
  • Ramos, Rafel
  • Serena, Joaquín
  • Ramió Torrentà, Lluís
  • Pineda, Víctor
  • Daunis-i-Estadella, Pepus
  • Thió-Henestrosa, Santiago
  • Barretina Ginesta, Jordi
  • Garre Olmo, Josep
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
  • Puig, Josep
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Aging biology entails a cell/tissue deregulated metabolism that affects all levels of biological organization. Therefore, the application of “omic” techniques that are closer to phenotype, such as metabolomics, to the study of the aging process should be a turning point in the definition of cellular processes involved. The main objective of the present study was to describe the changes in plasma metabolome associated with biological aging and the role of sex in the metabolic regulation during aging. A high-throughput untargeted metabolomic analysis was applied in plasma samples to detect hub metabolites and biomarkers of aging incorporating a sex/gender perspective. A cohort of 1030 healthy human adults (45.9% females, and 54.1% males) from 50 to 98 years of age was used. Results were validated using two independent cohorts (1: n = 146, 53% females, 30–100 years old; 2: n = 68, 70% females, 19–107 years old). Metabolites related to lipid and aromatic amino acid (AAA) metabolisms arose as the main metabolic pathways affected by age, with a high influence of sex. Globally, we describe changes in bioenergetic pathways that point to a decrease in mitochondrial β-oxidation and an accumulation of unsaturated fatty acids and acylcarnitines that could be responsible for the increment of oxidative damage and inflammation characteristic of this physiological process. Furthermore, we describe for the first time the importance of gut-derived AAA catabolites in the aging process describing novel biomarkers that could contribute to better understand this physiological process but also age-related diseases., This research was funded by the Spanish Ministry of Science,Innovation, and Universities (grant RTI2018-099200-B- I00, and PID2022-143140OB-I00, co-funded by the European Regional Development Fund. “A way to build Europe”), and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2021SGR00990] and Department of Health [SLT002/16/00250])to R.P. The work is also supported by “la Caixa” Foundation (Grant Agreement LCF/PR/HR21/52410002) to M.J. IRBLleida is a CERCAProgramme/Generalitat of Catalonia. This work was also partiallysupported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, PI20/01090, and PI21/01361 (co-funded by the European Regional Development Fund. “A way to make Europe”), and the Catalan Government (AGAUR,#SGR2017-0734, ICREA Academia Award 2021) to J.M.F-R.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic signature of stroke recurrence after transient ischemic attack

  • Purroy, Francisco
  • Ois Santiago, Angel Javier
  • Jové, Mariona
  • Arque, Gloria
  • Sol, Joaquim
  • Mauri Capdevila, Gerard
  • Rodríguez-Campello, Ana
  • Pamplona, Reinald
  • Portero Otín, Manuel
  • Roquer, Jaume
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition.The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR., This study was supported by the Government of Catalonia-Agència de Gestió d'Ajuts Universitaris i de Recerca (FP: 2017SGR1628 and 2021SGR01479; RP: 2021SGR00990); Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future" and "A way to build Europe") (FP: PI17-01725, PI14/01574; M.P-O: PI 17-00134, 20-0155); the Spanish Ministry of Science, Innovation and Universities (RP: RTI2018-099200-B-I00 and PID2022-143140OB-I00); the Department of Health (RP: SLT002/16/00250); and the INVICTUS plus Research Network (Carlos III Health Institute) (FP, CT and GA: RD16-0019-0017; TS: RD16-0019-0012; AO and JR: RD16-0019-0012; AC: RD16-0019-0006. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya).